Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SenoRx, a manufacturer of medical devices for the diagnosis and treatment of breast cancer has launched EnCor, its flagship vacuum-assisted breast biopsy product, and its line of breast biopsy tissue markers in ten countries outside the US.
Subscribe to our email newsletter
SenoRx is partnering with local distributors who have breast imaging and/or interventional radiology franchises in Austria, Belgium, England, Hong Kong, Ireland, Luxembourg, The Netherlands, Singapore, Switzerland and Taiwan.
EnCor and SenoRx breast tissue markers have previously received the necessary regulatory clearances in the European Economic Community and in these and several other countries in Asia. EnCor is well-suited for markets outside the US, where practitioners currently perform a large percentage of their breast biopsies with ultrasound imaging. The companies believe that ultrasound is potentially the fastest-growing of our market segments on a worldwide basis, as well as in the US.
Lloyd Malchow, SenoRx president and CEO, said: “We successfully test marketed EnCor in several countries outside the US during the first half of 2007. Based on those test market results, we concluded that EnCor could be a valuable commercial opportunity outside the US and began establishing agreements with selected distributors to begin selling EnCor and our line of tissue markers. We intend to further expand marketing of our products in additional countries beginning in 2008.”